Tokyo Tape
Sign in
← Nipro

Quarterly report · Q3

8086.TEDINET S100STZ2
Period2023-04-01 → 2023-12-31
Filed2024-02-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 36
MetricValuePeriodScopeSource row
Revenue¥439.1bn2023-04-01 → 2023-12-31Cons.Net sales
Revenue¥545.2bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥406.3bn2022-04-01 → 2022-12-31Cons.Net sales
Operating income¥22.4bn2023-04-01 → 2023-12-31Cons.Operating income
Operating income¥13.2bn2022-04-01 → 2022-12-31Cons.Operating income
Ordinary income¥20.0bn2023-04-01 → 2023-12-31Cons.Ordinary income
Ordinary income¥15.3bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥13.8bn2022-04-01 → 2022-12-31Cons.Ordinary income
Profit before tax¥22.1bn2023-04-01 → 2023-12-31Cons.Income before income taxes
Profit before tax¥14.7bn2022-04-01 → 2022-12-31Cons.Income before income taxes
Net income (owners)¥12.6bn2023-04-01 → 2023-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥4.6bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥7.0bn2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income¥13.5bn2023-04-01 → 2023-12-31Cons.Profit loss
Net income¥8.1bn2022-04-01 → 2022-12-31Cons.Profit loss
Total assets¥1.11Tat 2023-12-31Cons.Assets
Total assets¥1.03Tat 2023-03-31Cons.Assets
Total assets¥1.05Tat 2022-12-31Cons.Total assets (5-year summary)
Total liabilities¥831.3bnat 2023-12-31Cons.Liabilities
Total liabilities¥785.2bnat 2023-03-31Cons.Liabilities
Net assets / equity¥280.6bnat 2023-12-31Cons.Net assets
Net assets / equity¥242.2bnat 2023-03-31Cons.Net assets
Net assets / equity¥240.2bnat 2022-12-31Cons.Net assets (5-year summary)
Cash and deposits¥79.4bnat 2023-12-31Cons.Cash and deposits
Cash and deposits¥89.7bnat 2023-03-31Cons.Cash and deposits
EPS (basic)¥77.442023-04-01 → 2023-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥16.552023-10-01 → 2023-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥28.052022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥42.692022-04-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥4.352022-10-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥68.612023-04-01 → 2023-12-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥24.852022-04-01 → 2023-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥37.822022-04-01 → 2022-12-31Cons.Diluted earnings per share (5-year summary)
Equity ratio21.9%at 2023-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio20.1%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio21.3%at 2022-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 54
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2023-04-01 → 2023-12-31¥3.8bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2023-04-01 → 2023-12-31¥642m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2023-04-01 → 2023-12-31¥3.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-04-01 → 2023-12-31−¥200m
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-12-31−¥54.6bn
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-12-31−¥54.6bn
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-12-31−¥19.8bn
jpcrp040300-q3r_E02688-000Medical Treatment Relatedreportable segmentrevenue2023-04-01 → 2023-12-31¥345.3bn
jpcrp040300-q3r_E02688-000Medical Treatment Relatedreportable segmentrevenue external2023-04-01 → 2023-12-31¥340.3bn
jpcrp040300-q3r_E02688-000Medical Treatment Relatedreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥5.0bn
jpcrp040300-q3r_E02688-000Medical Treatment Relatedreportable segmentsegment profit2023-04-01 → 2023-12-31¥35.4bn
jpcrp040300-q3r_E02688-000Medicine Relatedreportable segmentrevenue2023-04-01 → 2023-12-31¥96.0bn
jpcrp040300-q3r_E02688-000Medicine Relatedreportable segmentrevenue external2023-04-01 → 2023-12-31¥54.2bn
jpcrp040300-q3r_E02688-000Medicine Relatedreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥41.8bn
jpcrp040300-q3r_E02688-000Medicine Relatedreportable segmentsegment profit2023-04-01 → 2023-12-31¥5.3bn
jpcrp040300-q3r_E02688-000Pharma Packagingreportable segmentrevenue2023-04-01 → 2023-12-31¥48.6bn
jpcrp040300-q3r_E02688-000Pharma Packagingreportable segmentrevenue external2023-04-01 → 2023-12-31¥43.9bn
jpcrp040300-q3r_E02688-000Pharma Packagingreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥4.7bn
jpcrp040300-q3r_E02688-000Pharma Packagingreportable segmentsegment profit2023-04-01 → 2023-12-31¥1.6bn
—segment totalrevenue2023-04-01 → 2023-12-31¥490.0bn
—segment totalrevenue external2023-04-01 → 2023-12-31¥438.5bn
—segment totalrevenue intersegment2023-04-01 → 2023-12-31¥51.5bn
—segment totalsegment profit2023-04-01 → 2023-12-31¥42.3bn
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-12-31¥493.7bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-12-31¥439.1bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-04-01 → 2023-12-31¥54.6bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-12-31¥42.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-04-01 → 2022-12-31¥3.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-04-01 → 2022-12-31¥530m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-04-01 → 2022-12-31¥2.6bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2022-12-31¥166m
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-12-31−¥28.6bn
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-12-31−¥28.6bn
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-12-31−¥22.5bn
jpcrp040300-q3r_E02688-000Medical Treatment Relatedreportable segmentrevenue2022-04-01 → 2022-12-31¥318.8bn
jpcrp040300-q3r_E02688-000Medical Treatment Relatedreportable segmentrevenue external2022-04-01 → 2022-12-31¥314.2bn
jpcrp040300-q3r_E02688-000Medical Treatment Relatedreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥4.6bn
jpcrp040300-q3r_E02688-000Medical Treatment Relatedreportable segmentsegment profit2022-04-01 → 2022-12-31¥30.8bn
jpcrp040300-q3r_E02688-000Medicine Relatedreportable segmentrevenue2022-04-01 → 2022-12-31¥70.3bn
jpcrp040300-q3r_E02688-000Medicine Relatedreportable segmentrevenue external2022-04-01 → 2022-12-31¥53.6bn
jpcrp040300-q3r_E02688-000Medicine Relatedreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥16.8bn
jpcrp040300-q3r_E02688-000Medicine Relatedreportable segmentsegment profit2022-04-01 → 2022-12-31¥2.2bn
jpcrp040300-q3r_E02688-000Pharma Packagingreportable segmentrevenue2022-04-01 → 2022-12-31¥42.6bn
jpcrp040300-q3r_E02688-000Pharma Packagingreportable segmentrevenue external2022-04-01 → 2022-12-31¥38.0bn
jpcrp040300-q3r_E02688-000Pharma Packagingreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥4.6bn
jpcrp040300-q3r_E02688-000Pharma Packagingreportable segmentsegment profit2022-04-01 → 2022-12-31¥2.5bn
—segment totalrevenue2022-04-01 → 2022-12-31¥431.7bn
—segment totalrevenue external2022-04-01 → 2022-12-31¥405.8bn
—segment totalrevenue intersegment2022-04-01 → 2022-12-31¥25.9bn
—segment totalsegment profit2022-04-01 → 2022-12-31¥35.5bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-12-31¥434.9bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-12-31¥406.3bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-12-31¥28.6bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-12-31¥35.7bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 445
ItemContextValueUnit
Other elCurrentYTDDuration763000000JPY
Extraordinary lossPrior1YTDDuration2782000000JPY
Extraordinary lossCurrentYTDDuration3092000000JPY
Income before income taxesPrior1YTDDuration14724000000JPY
Income before income taxesCurrentYTDDuration22082000000JPY
Income taxes currentPrior1YTDDuration5649000000JPY
Income taxes currentCurrentYTDDuration7562000000JPY
Income taxes deferredPrior1YTDDuration1008000000JPY
Income taxes deferredCurrentYTDDuration1018000000JPY
Income taxesPrior1YTDDuration6658000000JPY
Income taxesCurrentYTDDuration8581000000JPY
Profit lossPrior1YTDDuration8065000000JPY
Profit lossCurrentYTDDuration13501000000JPY
Profit loss attributable to non controlling interestsPrior1YTDDuration1103000000JPY
Profit loss attributable to non controlling interestsCurrentYTDDuration871000000JPY
Profit loss attributable to owners of parentPrior1YTDDuration6962000000JPY
Profit loss attributable to owners of parentCurrentYTDDuration12629000000JPY
Profit lossPrior1YTDDuration8065000000JPY
Profit lossCurrentYTDDuration13501000000JPY
Valuation difference on available for sale securities net of tax ociPrior1YTDDuration-2859000000JPY
Valuation difference on available for sale securities net of tax ociCurrentYTDDuration-690000000JPY
Deferred gains or losses on hedges net of tax ociPrior1YTDDuration55000000JPY
Deferred gains or losses on hedges net of tax ociCurrentYTDDuration-6000000JPY
Foreign currency translation adjustment net of tax ociPrior1YTDDuration35845000000JPY
Foreign currency translation adjustment net of tax ociCurrentYTDDuration27900000000JPY
Remeasurements of defined benefit plans net of tax ociPrior1YTDDuration383000000JPY
Remeasurements of defined benefit plans net of tax ociCurrentYTDDuration-171000000JPY
Share of other comprehensive income of associates accounted for using equity method ociPrior1YTDDuration2152000000JPY
Share of other comprehensive income of associates accounted for using equity method ociCurrentYTDDuration767000000JPY
Other comprehensive incomePrior1YTDDuration35577000000JPY
Other comprehensive incomeCurrentYTDDuration27799000000JPY
Comprehensive incomePrior1YTDDuration43643000000JPY
Comprehensive incomeCurrentYTDDuration41300000000JPY
Comprehensive income attributable to owners of the parentPrior1YTDDuration42204000000JPY
Comprehensive income attributable to owners of the parentCurrentYTDDuration40197000000JPY
Comprehensive income attributable to non controlling interestsPrior1YTDDuration1439000000JPY
Comprehensive income attributable to non controlling interestsCurrentYTDDuration1103000000JPY
Exporting notes receivable discountedPrior1YearInstant－JPY
Exporting notes receivable discountedCurrentQuarterInstant7000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q3r_E02688-000MedicalTreatmentRelatedReportableSegmentsMember314226000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q3r_E02688-000MedicineRelatedReportableSegmentsMember53553000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q3r_E02688-000PharmaPackagingReportableSegmentMember37990000000JPY
Revenues from external customersPrior1YTDDuration_ReportableSegmentsMember405770000000JPY
Revenues from external customersPrior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember530000000JPY
Revenues from external customersPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember406301000000JPY
Revenues from external customersPrior1YTDDuration_ReconcilingItemsMember－JPY
Revenues from external customersPrior1YTDDuration406301000000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q3r_E02688-000MedicalTreatmentRelatedReportableSegmentsMember4597000000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q3r_E02688-000MedicineRelatedReportableSegmentsMember16772000000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q3r_E02688-000PharmaPackagingReportableSegmentMember4571000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass rounding
balance sheet identityconsolidated 2023-12-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2023-04-01/2023-12-31pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-12-31pass